Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar;53(3):354-361.
doi: 10.1007/s00535-017-1407-1. Epub 2017 Nov 14.

World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat

Hidekazu Suzuki  1 , Hideki Mori  2
Affiliations
Review

World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat

Hidekazu Suzuki et al. J Gastroenterol. 2018 Mar.

Abstract

Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering regional differences in resistance to clarithromycin and metronidazole. Quinolones and rifabutin-containing regimens are useful as third- and fourth-line rescue therapies.

Keywords: Clarithromycin; Fluoroquinolone; Gastric cancer; H. pylori; Metronidazole.

PubMed Disclaimer

Conflict of interest statement

During the last 2 years, H.S. received scholarship funds for the research from Daiichi-Sankyo Co., Otsuka Pharmaceutical Co. Ltd., and Tsumura Co., and received service honoraria from Astellas Pharma Inc, AstraZeneca K.K., Daiichi-Sankyo Co., Otsuka Pharmaceutical Co. Ltd., Mylan EPD Co., Takeda Pharmaceutical Co., Ltd., and Zeria Pharmaceutical Co. Ltd.

Figures

Fig. 1
Fig. 1
The relationship between geographic distribution of the prevalence of H. pylori infection and the gastric cancer incidence is described. The gastric cancer incidence is generally in direct proportion to the prevalence of H. pylori infection. However, higher incidences of gastric cancer are found in East Asian countries than in the other countries
Fig. 2
Fig. 2
The geographic distribution of resistance to clarithromycin and metronidazole is described. There is only a limited relationship between geographic factor and the resistance to clarithromycin and metronidazole
Fig. 3
Fig. 3
Strategy on treatment of H. pylori infection is shown in accordance with the Maastricht V/Florence Consensus Report [40]
See this image and copyright information in PMC

Comment in

References

    1. Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014;15(3):306–316. doi: 10.1016/j.chom.2014.02.008. - DOI - PubMed
    1. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–789. doi: 10.1056/NEJMoa001999. - DOI - PubMed
    1. Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367. doi: 10.1136/gutjnl-2015-309252. - DOI - PMC - PubMed
    1. Suzuki H, Mori H. Helicobacter pylori: Helicobacter pylori gastritis-a novel distinct disease entity. Nat Rev Gastroenterol Hepatol. 2015;12(10):556–557. doi: 10.1038/nrgastro.2015.158. - DOI - PubMed
    1. Suzuki H, Mori H. Different pathophysiology of gastritis between East and West? An Asian perspective. Inflamm Intest Dis. 2016;1(3):123–128. doi: 10.1159/000446301. - DOI - PMC - PubMed

MeSH terms